Header Logo

Connection

DAVID POPLACK to Trimetrexate

Back to Details
This is a "connection" page, showing publications DAVID POPLACK has written about Trimetrexate.
DAVID POPLACK
Connection Strength
0.034
Trimetrexate
  1. Pharmacokinetics of trimetrexate (NSC 352122) in monkeys. Cancer Res. 1986 Jan; 46(1):169-74.
    View in: PubMed
    Score: 0.016
  2. Characterization of cross-resistance to methotrexate in a human breast cancer cell line selected for resistance to melphalan. Biochem Pharmacol. 1995 Apr 18; 49(8):1069-78.
    View in: PubMed
    Score: 0.008
  3. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Isr J Med Sci. 1988 Sep-Oct; 24(9-10):477-82.
    View in: PubMed
    Score: 0.005
  4. Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1988 Mar; 32(3):324-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.